Načítá se...
Chimeric antigen receptor engineered stem cells: a novel HIV therapy
Despite the success of combination antiretroviral therapy (cART) for suppressing HIV and improving patients’ quality of life, HIV persists in cART-treated patients and remains an incurable disease. Financial burdens and health consequences of lifelong cART treatment call for novel HIV therapies that...
Uloženo v:
Vydáno v: | Immunotherapy |
---|---|
Hlavní autoři: | , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Future Medicine Ltd
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5618937/ https://ncbi.nlm.nih.gov/pubmed/28357916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2016-0121 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|